ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43181
-0.03%
Bitcoin
96,854.27
-0.93%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Elevation Oncology Inc (ELEV) Share Price

Elevation Oncology Inc

Elevation Oncology Inc (ELEV)

NASDAQ
0.58
-0.0457
(-7.30%)
Closed December 21 3:00PM
Delayed by 15 minutes
0.608
0.028
(4.83%)
After Hours: 6:58PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.608
Bid
0.59
Ask
0.6171
Volume
2,504,348
0.55 Day's Range 0.66
0.4401 52 Week Range 5.8299
Market Cap
35.944M
Previous Close
0.6257
Open
0.62
Last Trade
2300
@
0.608
(formt)
Last Trade Time
Financial Volume
US$ 1,552,666
VWAP
0.619988
Average Volume (3m)
712,859
Shares Outstanding
59,119,055
Dividend Yield
-
PE Ratio
-0.72
Earnings Per Share (EPS)
-0.77
Revenue
-
Net Profit
-45.7M

About Elevation Oncology Inc

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.elevationoncology.com
Headquarters
Camden, Delaware, USA
Founded
-
Elevation Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ELEV. The last closing price for Elevation Oncology was US$0.63. Over the last year, Elevation Oncology shares have traded in a share price range of US$ 0.4401 to US$ 5.8299.

Elevation Oncology currently has 59,119,055 shares outstanding. The market capitalization of Elevation Oncology is US$36.99 million. Elevation Oncology has a price to earnings ratio (PE ratio) of -0.72.

Ask ADVFN Intelligence (AI)

ELEV Latest News

More News

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors PR Newswire BOSTON, Dec. 12, 2024 -- EO-1022 is comprised of...

December 12 2024
PR Newswire (US)

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 PR...

December 05 2024
PR Newswire (US)

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire BOSTON, Nov. 26, 2024 BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq:...

November 26 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

November 19 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 06 2024
Edgar (US Regulatory)

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, Nov. 6, 2024 -- Promising initial Phase 1 data of EO-3021 reported...

November 06 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 06 2024
Edgar (US Regulatory)

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing...

September 23 2024
PR Newswire (US)

Form 8-K - Current report

September 20 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0634-9.442955019360.67140.70.567640900.63961148CS
4-0.0022-0.3605375286790.61020.80990.567439350.65001628CS
120.03265.66562391380.57540.80990.57128590.60291768CS
26-2.172-78.12949640292.783.280.59704791.07352699CS
520.09819.21568627450.515.82990.440114091992.1643119CS
156-3.762-86.08695652174.376.8660.3637798672.55795074CS
260-13.392-95.65714285711416.220.3636807792.66232168CS

ELEV - Frequently Asked Questions (FAQ)

What is the current Elevation Oncology share price?
The current share price of Elevation Oncology is US$ 0.608
How many Elevation Oncology shares are in issue?
Elevation Oncology has 59,119,055 shares in issue
What is the market cap of Elevation Oncology?
The market capitalisation of Elevation Oncology is USD 36.99M
What is the 1 year trading range for Elevation Oncology share price?
Elevation Oncology has traded in the range of US$ 0.4401 to US$ 5.8299 during the past year
What is the PE ratio of Elevation Oncology?
The price to earnings ratio of Elevation Oncology is -0.72
What is the reporting currency for Elevation Oncology?
Elevation Oncology reports financial results in USD
What is the latest annual profit for Elevation Oncology?
The latest annual profit of Elevation Oncology is USD -45.7M
What is the registered address of Elevation Oncology?
The registered address for Elevation Oncology is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934
What is the Elevation Oncology website address?
The website address for Elevation Oncology is www.elevationoncology.com
Which industry sector does Elevation Oncology operate in?
Elevation Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

ELEV Discussion

View Posts
willlbone willlbone 4 months ago
Will test the one year low at 36 cents. Sell for now.
👍️0
Disquisition Disquisition 4 months ago
ELEVated DUMPING
👍️0
KOmani KOmani 4 months ago
Shorts really smothered this.

As soon as someone hit the bid with a sell, they put up sells $0.0001 above the last sale.

Book value is over $1.30, so this seems like an overreaction, but with that type of smothering, it's hard to see a bounce.
👍️0
Monksdream Monksdream 5 months ago
ELEV under $4
👍️0
glenn1919 glenn1919 5 months ago
ELEV.......................................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 months ago
ELEV under $5
👍️0
glenn1919 glenn1919 9 months ago
ELEV....................................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
ELEV....................................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
Diver66 Diver66 11 months ago
Here comes the death spiral!!! Under a dollar by end of the day....
👍️0
glenn1919 glenn1919 11 months ago
ELEV.....................................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
Golden Cross Golden Cross 11 months ago
Shooting for $5 now
👍️0
glenn1919 glenn1919 12 months ago
ELEV..................................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
ELEV new 52 week low
👍️0
gdog gdog 1 year ago
Item 8.01

Other Events.

On August 16, 2023, Elevation Oncology, Inc. (the “Company”) announced that the first patient has been dosed in the Phase 1 clinical trial evaluating EO-3021 in patients with advanced unresectable or metastatic solid tumors likely to express Claudin 18.2 including gastric, gastroesophageal junction, pancreatic or esophageal cancers. The Company expects to report preliminary safety and anti-tumor data from its Phase 1 study during the first half of 2025.
👍️0
gdog gdog 1 year ago
thxs anyhow
👍️0
Monksdream Monksdream 1 year ago
Not I
👍️0
gdog gdog 1 year ago
anyone know when the clinical trial will be over???????
👍️0
Monksdream Monksdream 1 year ago
ELEV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
ELEV new 52 week low
👍️0
willlbone willlbone 2 years ago
Dilution. Bid 99 cents.
👍️0
willlbone willlbone 2 years ago
ELEVator going down to the basement.
Bid $1.50
👍️0
glenn1919 glenn1919 2 years ago
ELEV.........................https://stockcharts.com/h-sc/ui?s=ELEV&p=W&b=5&g=0&id=p86431144783
👍️0
KeepOn KeepOn 2 years ago
Unbelievable.
👍️0
Invest-in-America Invest-in-America 2 years ago
Indeed, Sir!! Hey, Bro, and such is WHY (the late) Steve Jobs --- a chap who had unlimited bucks to spend on (so-called) "DOCTORS" --- finally ran down to the Great Nation of MEXICO in his finals days; desperately seeking whatever "NATURAL" herbs, berries, roots, tree-bark, or whatnot, he could shove in his mouth to HOPEFULLY fix his grossly-diseased (Cancerous) body --- into which the (mindless) USA Doctors had TRANSPLANTED used Human organs from the American Medical Associations', "PICK-&-PULL-HUMAN-BODY-PARTS-JUNK-YARDS"!!!!
👍️0
tw0122 tw0122 2 years ago
Well said !! it’s in the doctors financial interest to find what COULD be wrong with you to make themselves MUCH DINERO especially if your a senior on Medicare they will have you on excessive medications and doing unnecessary tests.
👍️0
The Night Stalker The Night Stalker 2 years ago
shitty dip and rip, my asshat DRMA in same boat,will average down next week
👍️0
Invest-in-America Invest-in-America 2 years ago
HUGE things are WRONG with death!! On this miscreant, ignorant, superstitious, reprobate Planet, we invariably hear from the Media --- every few days or so --- how this-or-that CELEBRITY "PASSED-AWAY" of whatever "DESEASE" after "FIGHTING A 3-YEAR BATTLE" with that "DISEASE". WRONG, WRONG, WRONG, WRONG!!!!!!!

The ONLY disease that kills ALL of us eventually is the GROSS IGNORANCE of the so-called "DOCTORS" who can NOT cure us, fix us, heal us, nor otherwise save us from ANY MEDICAL AFFLICTIONS!!!!!!!!!!!!!!!!! Hey, Bro, when YOU yourself go in for your likely "ANNUAL WORKUP" at your "FAMILY PHYSICIAN'S" office or hospital, he or she will first assess all of your (supposed) "RISK FACTORS". In TRUTH, however, the ONLY risk factor you Sir will ever have during your entire life is that DOCTOR himself!!!!!!!

ENOUGH said by me on that subject!!! YOU, Sir, have now been EDIFIED!!!!
👍️0
The Night Stalker The Night Stalker 2 years ago
Patch Adams:
What's wrong with death sir? What are we so mortally afraid of? Why can't we treat death with a certain amount of humanity and dignity, and decency, and God forbid, maybe even humor. Death is not the enemy gentlemen. If we're going to fight a disease, let's fight one of the most terrible diseases of all, indifference.
👍️0
The Night Stalker The Night Stalker 2 years ago
something about kinky nuns makes the blood flowing/ragging down therehttps://investorshub.advfn.com/Elevation-Oncology-Inc-41322
👍️0
Invest-in-America Invest-in-America 2 years ago
Hey, Bro, let's both face MECCA, the VATICAN, or Mt. SINAI, six times per day while PRAYING very hard, and maybe THAT will help this Planet.





👍️0
The Night Stalker The Night Stalker 2 years ago
line from Forrest Gump

well, i am ACTUALLY crippled, been in a wheelchair 20 years i have 5 diseases

https://en.wikipedia.org/wiki/Friedreich%27s_ataxia
👍️0
Invest-in-America Invest-in-America 2 years ago
"That's what all these cripples down at the VA talk about: Jesus this and Jesus that. They even had a priest come and talk to me. He said God is listening and if I found Jesus, I'd get to walk beside him in the kingdom of Heaven. Did you hear what I said? WALK beside him in the kingdom of Heaven! Well kiss my crippled ass. God is listening? What a crock of shit."


PS: I fully CONCUR with your quote there, Homeboy --- been a card-carrying ATHEIST since age 10. And I'm a VET, to boot. Indeed, just had my annual with my VA WITCH DOCTOR, who can't fix ANYTHING --- let alone the AGING process, nor DEATH. Bottom line, Sir, is that we reside on the most PRIMITIVE Planet in the COSMOS!!!
👍️0
The Night Stalker The Night Stalker 2 years ago
recent pop now the flop
👍️0
The Night Stalker The Night Stalker 2 years ago
dippers
👍️0
Mt. Blanc Mt. Blanc 2 years ago
ELEV explodes.

Excellent clues weeks ago.

Watching VINC for some fireworks as the bios get bidding.

mb
👍️0
Mt. Blanc Mt. Blanc 2 years ago
20,000,000 20 million reasons to get in the ball game today.

ELEV may have some legs going into April.

mb
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=ELEV&p=d
👍️0
Invest-in-America Invest-in-America 2 years ago
ELEV: May end-up as the only WINNER of this day; in light of the typical GAP-&-CRASH volatility of everything else these days!!
👍️0
81vette 81vette 2 years ago
Responding well to vol,no naked shorting bs,set up nice for power hr and after hrs/pre-mkt for whatever news is coming
👍️0
81vette 81vette 2 years ago
7Xs ave vol,merger maybe coming,something is coming for insiders to be buying,I loaded up,risk reward looks good to me
👍️0
RNsidersbuying RNsidersbuying 2 years ago
ELEV 1.31 - what message are the 'sellers' trying to convey?

23.3M O/S
$134M CASH
$10.4M Total Liability

That management here are a host of imbeciles that will piss off the remaining $125M CASH or approx. $5.35 per share on Country Club memberships and fast cars? OUCH, serious low blow to a host of egos?

Fast approaching my largest position, ever...
👍️0

Your Recent History

NASDAQ
ELEV
Elevation Oncology
BIT
S31322
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads